These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 32966982

  • 1. Effectiveness, Safety, and Health-Related Quality of Life of Chronic Migraine Patients Treated with Onabotulinum Toxin A.
    Beckmann Y, Çetin Üncü F, Kurt İncesu T, Türe S.
    Eur Neurol; 2020; 83(5):517-522. PubMed ID: 32966982
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Botulinum toxin type A and acute drug costs in migraine with triptan overuse.
    Christie SN, Giammarco R, Gawel M, Mackie G, Gladstone J, Becker WJ.
    Can J Neurol Sci; 2010 Sep; 37(5):588-94. PubMed ID: 21059503
    [Abstract] [Full Text] [Related]

  • 6. Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial.
    Mathew NT, Frishberg BM, Gawel M, Dimitrova R, Gibson J, Turkel C, BOTOX CDH Study Group.
    Headache; 2005 Apr; 45(4):293-307. PubMed ID: 15836565
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. BoNT-A efficacy in high frequency migraine: an open label, single arm, exploratory study applying the PREEMPT paradigm.
    Martinelli D, Arceri S, De Icco R, Allena M, Guaschino E, Ghiotto N, Bitetto V, Castellazzi G, Cosentino G, Sances G, Tassorelli C.
    Cephalalgia; 2022 Feb; 42(2):170-175. PubMed ID: 34404257
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Chronic Cannabis Use and Treatment Failure of Onabotulinum Toxin A for Chronic Migraine.
    Chan TLH, Zhang N.
    Can J Neurol Sci; 2019 Nov; 46(6):785-786. PubMed ID: 31469061
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Onabotulinum toxin A (Botox) for chronic migraine treatment: an Italian experience.
    Grazzi L, Usai S.
    Neurol Sci; 2015 May; 36 Suppl 1():33-5. PubMed ID: 26017508
    [Abstract] [Full Text] [Related]

  • 16. Botulinum toxin: A review of the mode of action in migraine.
    Do TP, Hvedstrup J, Schytz HW.
    Acta Neurol Scand; 2018 May; 137(5):442-451. PubMed ID: 29405250
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Efficacy, safety, and predictors of response to botulinum toxin type A in refractory chronic migraine: a retrospective study.
    Lin KH, Chen SP, Fuh JL, Wang YF, Wang SJ.
    J Chin Med Assoc; 2014 Jan; 77(1):10-5. PubMed ID: 24269600
    [Abstract] [Full Text] [Related]

  • 19. Is Botox Right for Me: When to Assess the Efficacy of the Botox Injection for Chronic Migraine in Pediatric Population.
    Goenka A, Yu SG, George MC, Chikkannaiah M, MacDonald S, Stolfi A, Kumar G.
    Neuropediatrics; 2022 Oct; 53(5):344-350. PubMed ID: 35453165
    [Abstract] [Full Text] [Related]

  • 20. Botulinum Toxin Type A for the Treatment of Post-traumatic Headache: A Randomized, Placebo-Controlled, Cross-over Study.
    Zirovich MD, Pangarkar SS, Manh C, Chen L, Vangala S, Elashoff DA, Izuchukwu IS.
    Mil Med; 2021 May 03; 186(5-6):493-499. PubMed ID: 33241323
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.